Read the full story on OneWorld South Asia.
Roche has granted a sub-license to the Indian company Hetero Drugs for the production of oseltamivir (Tamiflu), as part of continued efforts to increase and speed up availability of the medicine for influenza pandemic planning world wide. The agreement with Hetero is focused on providing oseltamivir for government pandemic use and will have an immediate effect on the availability in India and developing countries both directly and through further agreements with local companies, states a Roche release.
Tuesday, January 03, 2006
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment